NICE publishes seven technology appraisals in October 2017

NICE publishes TAs on autologous chondrocyte implantation, brentuximab, reslizumab, tofacitinib, and immunosuppressive therapy for kidney transplant.

Register or subscribe to view this content

Please sign in to continue reading this content, or …

Register for FREE

Guidelines for Nurses is free for UK-based doctors, nurses, and pharmacists.

Sign-up now—it takes just a few minutes and you’ll get unlimited access to all of our content, including summaries, expert articles, tools and resources, and CPD modules.

Or read for £5

Pay £5.00 to continue reading this content.

This will entitle you to unlimited access to our summaries, expert articles, and CPD modules for 30 days.